Henry R. Lambert

Henry R. Lambert is a declared insider of Pure Bioscience, Inc., with filings sourced from SEC (Form 4). Between 23 October 2013 and 13 August 2018, the trades on record add up to 13 filings.

Both buying and selling appear: 2 purchases worth €44k, against 7 sales worth €35k. Taken together, the purchases exceed the sales by €9,075. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 4 share grants. So far in 2018, the count stands at no purchases and 5 sales.

On 15 August 2018 came the latest disclosure, a share grant in Pure Bioscience, Inc. The clock since the last published purchase (31 July 2015) now reads 4,119 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.